Omada Health reported a gross margin of 72.62% and a net margin of 6.03% for the quarter ended Jun 2026. These financial ratios cover 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||
| Gross Margin | 60.26% | 62.75% | 66.97% | 58.04% | 65.68% | 66.25% | 70.75% | 62.39% | 72.62% |
| EBT Margin | -25.94% | -20.27% | -17.20% | -17.19% | -8.65% | -4.67% | 6.80% | -3.81% | 6.03% |
| EBIT Margin | -24.35% | -18.73% | -14.80% | -15.28% | -7.08% | -3.69% | 4.33% | -6.13% | 4.04% |
| EBITDA Margin | -24.35% | -18.73% | -14.80% | -15.28% | -7.08% | -3.69% | 4.33% | -6.13% | 4.04% |
| Operating Margin | -24.35% | -18.73% | -14.80% | -15.28% | -7.08% | -3.69% | 4.33% | -6.13% | 4.04% |
| Net Margin | -25.94% | -20.27% | -17.20% | -17.19% | -8.65% | -4.67% | 6.80% | -3.81% | 6.03% |
| FCF Margin | 0.14% | -15.16% | -31.02% | 3.06% | 12.76% | 26.68% | -17.06% | 2.83% | |
| Efficiency | |||||||||
| Inventory AverageInventory Avg. | 3.31M | 3.82M | 4.16M | 3.98M | |||||
| Assets AverageAssets Avg. | 295.22M | 296.44M | 304.10M | 315.51M | |||||
| Invested CapitalInvested Cap. | -354.63M | 244.18M | 217.35M | 229.68M | |||||
| Asset Utilization RatioAsset Util. | 0.79 | 0.88 | 0.93 | 0.98 | |||||
| Leverage & Solvency | |||||||||
| Interest Coverage RatioInterest Cover | -8.87 | -7.43 | -6.47 | -7.82 | -3.97 | -7.12 | 252.38 | -265.61 | 253.50 |
| Debt Ratio | 0.20 | 0.10 | |||||||
| Times Interest Earned | -8.87 | -7.43 | -6.47 | -7.82 | -3.97 | -7.12 | 252.38 | -265.61 | 253.50 |
| Valuation | |||||||||
| Price to EarningsP/E | -75.71 | -402.73 | 112.07 | -250.72 | 251.28 | ||||
| Price to SalesP/S | 6.55 | 18.81 | 7.62 | 9.54 | 15.15 | ||||
| Price to BookP/B | 1.88 | 5.89 | 2.52 | 3.18 | 5.26 | ||||
| Enterprise Value | 178.92M | 1,081.25M | 356.13M | 532.88M | 1,108.59M | ||||
| EV to EBIT | -41.19 | -430.26 | 108.54 | -111.46 | 312.37 | ||||
| EV to EBITDA | -41.19 | -430.26 | 108.54 | -111.46 | 312.37 | ||||
| Market Capitalization | 402.07M | 1,279.88M | 578.16M | 744.65M | 1,330.30M | ||||
| Price to FCFP/FCF | 213.98 | 147.40 | 28.58 | -55.93 | 534.47 | ||||
| EV to FCF | 95.22 | 124.53 | 17.60 | -40.03 | 445.40 | ||||
| EV to CFO | 62.60 | 106.71 | 16.66 | -45.03 | 276.66 | ||||
| Return Ratios | |||||||||
| Return on Sales [ROS]ROS | -24.35% | -18.73% | -14.80% | -15.28% | -7.08% | -3.69% | 4.33% | -6.13% | 4.04% |
| Return on Capital Employed [ROCE]ROCE | -9.93% | -5.42% | -3.55% | -0.19% | |||||
| Return on Assets [ROA]ROA | -8.87% | -4.31% | -2.07% | 1.36% |